[Immunological and transfusiological approaches to limiting the risk of leukemia related to the accident at the Chernobyl nuclear power plant].
A programme including prophylactic, diagnostic aspects and reasons for the therapeutic tactics has been proposed for narrowing leukemia consequences related to the catastrophe at Chernobyl NPS. The state of the All-Union Register of typed donors and All-Union standard of typing sera has been considered. It is necessary to make reserves of blood containing no antibodies to cytomegalovirus (CMV-negative blood).
Zaretskaia
Iu M
IuM
D000059:Accidents; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology / Q000528:radiation effects*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D007953:Leukemia, Radiation-Induced / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D009688:Nuclear Reactors; D011210:Power Plants; D011847:Radioactive Fallout / Q000009:adverse effects*; D014455:Ukraine
D006680:HLA Antigens; D011847:Radioactive Fallout
Immunologicheskie i transfuziologicheskie podkhody k ogranicheniiu leĭkozogennoĭ situatsii, sviazannoĭ s avarieĭ na Chernobyl'skoĭ AES.